Dr. Amadou Amani advances Crohn’s disease research by supporting a grants portfolio focused on defining disease drivers and accelerating strategies to prevent onset, recurrence and progression. With a background in microbiology, immunology and translational therapeutics, she brings expertise in immune-mediated disease mechanisms and preclinical development to efforts aimed at predicting risk and intercepting inflammatory bowel disease before irreversible damage occurs.